1.Effects of arsenic trioxide and paclitaxel on the expression level of MTA1 in Caco-2 cells
International Journal of Laboratory Medicine 2017;38(11):1461-1463,1467
Objective To explore the effects of arsenic trioxide and paclitaxel on the expression level of metastasis-associated gene 1(MTA1) mRNA in Caco-2 cells.Methods Methylthiazolyldiphenyl-tetrazolium bromide(MTT) assay was performed to detect the inhibition rate of different concentrations of arsenic trioxide and paclitaxel on the growth of Caco-2 cells,reverse transcription real-time polymerase chain reaction was performed to detect the expression level of MTA1 mRNA.Results With the increasing of the concentrations of arsenic trioxide and paclitaxel,the inhibition rate increased,while the expression level of MTA1 mRNA decreased.The inhibition rate was negatively correlated with the expression levle of MTA1 mRNA(r=-0.636,P<0.05).Conclusion The effects of arsenic trioxide and paclitaxel on the growth of Caco-2 cells and the expression level of MTA1 mRNA could be with dosage-dependence,and the inhibition effects might be negatively correlated with the expression level of MTA1 mRNA.
2.Distribution and drug resistance of 153 pathogen strains in blood culture
Youzhuo LIANG ; Canfeng CHEN ; Wei ZHOU
International Journal of Laboratory Medicine 2017;38(2):211-213
Objective To investigate the distribution and drug resistance of pathogen in blood culture from 2014 to 2015.Meth-ods 1 260 blood specimens were incubated in our hospital,the positive samples were isolation and identification and the drug resist-ance was analyzed.Results 153 strains of bacteria were isolated from 1 260 blood specimens,and the positive rate was 12.1%. Escherichia coli and Klebsiella pneumonia were the main pathogens in gram negative bacilli,coagulase negative Staphylococci and Staphylococcus aureus were the main pathogens in gram positive cocci,Imipenem and ertapenem were the most effective antibiotics (100.0%)to Escherichia coli and Klebsiella pneumonia,the gram-positive cocci were sensitve to Vanconmycin,linezolid and tigecy-cline.Conclusion Drug resistance of isolated pathogen in blood cultures is very serious.Monitoring the change of pathogens and trends of drug resistance is very important in guiding the clinical use of drug.
3.Research of hepatitis B virus genotyping and pre-existing antiviral resistance mutation in Shenzhen area
Canfeng CHEN ; Chuanvin XU ; Xuehui HUANG
International Journal of Laboratory Medicine 2014;(23):3190-3191
Objective To understand the hepatitis B virus(HBV)genotyping and pre-existing antiviral resistance mutation in the patients with clinical chronic HBV infection in Shenzhen area.Methods Serum samples in 244 cases of chronic HBV infection were detected for HBV genotyping and pre-existing antiviral resistance mutation by using PCR combined with reverse dot hybridization. Results In 244 cases of chronic HBV infection,3 kinds of genotype were found,including 143 cases(58.6%)of genotype B,100 ca-ses(41%)of genotype C and 1 case(0.4%)of genotype D;38 cases(15.57%)of pre-existing antiviral resistance mutation were de-tected out.The total detection rate of pre-existing antiviral resistance mutation was 15.57%,in which 22 cases(9.01%)were related with lamivudine resistance and 16 cases(6.56%)were related with adefovir dipivoxil resistance.Conclusion The genotype B and C are the main genotypes in Shenzhen area,and the incidence rate of pre-existing antiviral resistance mutation in the patients with chronic HBV infection is relatively high.The detection of genotyping and pre-existing antiviral resistance mutation of HBV has the important significance to predict the disease progression and guide the individulized treatment.
4.Analysis of pathogen distribution and drug resistance in patients with lung cancer complicating non-fermentative bacteria lung infection
Canfeng CHEN ; Youzhuo LIANG ; Wei ZHOU ; Weibo FENG ; Shaobao ZHENG ; Lingguang LI
International Journal of Laboratory Medicine 2015;(24):3578-3580
Objective To analyze the pathogen distribution and drug‐resistance characteristics in the patients with lung cancer complicating non‐fermentative bacteria lung infection to provide the basis for clinicians to prevent infection and rationally use anti‐bacterial drugs .Methods The clinically submitted respiratory tract specimens in the patients with lung cancer in our hospital from January 2009 to July 2015 were retrospectively analyzed .The isolated pathogenic bacteria were identified by adopting the France Bio‐plum‐Egyptian company Vitek2‐Compact identification instrument ,the drug sensitivity test was conducted by using the K‐B disk diffusion method .The statistical analysis of data was performed by adopting the WHONET 5 .6 software .Results 176 strains of non‐fermentative bacteria mainly came from sputum ,accounting for 80 .1% ,the detection rate of Pseudomonas aeruginosa was highest ,accounting for 48 .2% ,followed by Acinetobacter baumannii and Stenotrophomonas maltophilia ,accounting for 32 .4% and 16 .5% respectively ;the drug susceptibility test results showed that non‐fermentative bacteria had different degrees of resistance to antibacterial drugs or even multiple drug resistance ,in which the resistance of Pseudomonas aeruginosa to amikacin ,tobramycin and cefoperazone/sulbactam ,the resistance of Acinetobacter baumannii to amikacin ,cefoperazone/sulbactam and the resistance of Stenotrophomonas maltophilia to minocycline ,cotrimoxazole and cefoperazone/sulbactam were less than 30 .0% ,which to other an‐tibacterial drugs were more than 30 .0% .Conclusion Non‐fermentative bacteria are common pathogenic bacteria in hospital infec‐tion ,non‐fermentative bacteria isolated from the patients with lung cancer complicating pulmonary infection have serious resistance to commonly used antibacterial drugs ,therefore clinic should strengthen the monitoring of pathogenic bacteria and drug resistance . Cefoperazone/sulbactam is the first choice for treating these bacterial infections .
5.Oncologic safety of laparoscopic surgery in radical resection for different stage rectal cancer.
Chaoming TANG ; Canfeng CAI ; Guoxing CHEN
Chinese Journal of Gastrointestinal Surgery 2015;18(6):568-572
OBJECTIVETo evaluate the oncologic safety and short-term outcomes of laparoscopic surgery in early and advanced rectal cancers.
METHODSClinical and follow-up data of 186 cases with rectal cancer undergoing laparoscopic radical resection from June 2009 to December 2013 were analyzed retrospectively, including 48 early rectal cancer (stage 0-I) and 138 advanced cancer (stage II-III). Thirty-seven cases with early rectal cancer and 275 with advanced cancer undergoing open radical surgery were selected as control group. Surgical safety, oncologic safety and short-term outcomes were compared between two groups.
RESULTSAs for either early or advanced rectal cancer, there were no significant differences in the number of harvested lymph nodes, length of distal resection margin, complication morbidity, rate of local recurrence, distant metastasis, and 3-year survival rate between the two groups (all P>0.05). Although the operation time was longer in laparoscopic group, the laparoscopic group presented less intra-operative blood loss, faster recovery of bowel function, and shorter postoperative hospital stay (all P<0.05). As for advanced rectal cancer, laparoscopic radical surgery tended to achieve less lymph nodes dissected (mean, 13.5 vs. 15.0) and develop more anastomotic leakage (8.0% vs. 5.5%) compared to open surgery, although neither reached statistical significance (P=0.112, P=0.221). Moreover, the conversion rate in patients with advanced rectal cancer was significantly higher than that in those with early cancer (10.9% vs 2.1%, P=0.048).
CONCLUSIONSLaparoscopic surgery can obtain the same oncologic and surgical safety for early rectal cancer as compared to open surgery. However, due to higher conversion rate, potential risk of decreased number of harvested lymph nodes and increased anastomotic leakage, laparoscopic surgery for advanced rectal cancer should be carried out prudently, especially in some hospitals with less laparoscopic experience.
Digestive System Surgical Procedures ; Humans ; Laparoscopy ; Lymph Nodes ; Neoplasm Staging ; Operative Time ; Rectal Neoplasms ; Retrospective Studies ; Safety ; Survival Rate
6.Meta-analysis of Shenqi Fuzheng Injection Combined with Chemotherapy for Colorectal Cancer
Jianyu WU ; Weipeng SUN ; Haigan YANG ; Zijing ZHANG ; Canfeng HE ; Junmao WEN ; Yuzhong CHEN
China Pharmacy 2018;29(2):248-254
OBJECTIVE:To evaluate the clinical efficacy and safety of Shenqi fuzheng injection combined with chemotherapy in the treatment of colorectal cancer.METHODS:Retrieved from PubMed,EMBase,Clinical Trials,Cochrane Library,CJFD,CBM,Wanfang database and VIP,RCTs about Shenqi fuzheng injection combined with chemotherapy (trial group) vs.chemotherapy alone (control group) in the treatment of colorectal cancer were included.Meta-analysis was performed by Rev Man 5.3 statistical software after data extraction and quality evaluation with Cochrane system evaluator manual.RESULTS:A total of 25 RCTs were included,involving 1 987 patients.Results of Meta-analysis showed that objective remission rate of trial group was significantly higher than control group [RR=1.19,95% CI (1.02,1.39),P=0.02];the improvement of survival quality was significantly better than control group [RR=1.72,95%CI(1.49,1.99),P<0.001];CD4VCD8+ was significantly higher than control group [MD=0.40,95% CI (0.29,0.50),P<0.001];the incidence of gastrointestinal reaction was significantly higher than control group [RR=0.59,95%CI(0.52,0.68),P<0.001];the incidence of liver and renal injury was significantly lower than control group [RR=0.52,95%CI(0.41,0.67),P<0.001],with statistical significance.CONCLUSIONS:Shenqi fuzheng injection combined with chemotherapy can improve objective remission rate of colorectal cancer patients,survival quality and immune function,and reduce the occurrence of toxic reation.